Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,841 to 1,860 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Germinal center-derived lymphomas: The darkest side of humoral immunity. | Immunol Rev | 2019 | 30874354 | PubTator, text mining | PubMed |
| Defining a new nomenclature for the structures of active and inactive kinases. | Proc Natl Acad Sci U S A | 2019 | 30867294 | PubTator, text mining | PubMed |
| Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted Drugs. | Clin Cancer Res | 2019 | 30867219 | PubTator, text mining | PubMed |
| Amaranth's 2-Caffeoylisocitric Acid-An Anti-Inflammatory Caffeic Acid Derivative That Impairs NF-κB Signaling in LPS-Challenged RAW 264.7 Macrophages. | Nutrients | 2019 | 30866427 | PubTator, text mining | PubMed |
| Comparing the effects of vitamin E tocotrienol-rich fraction supplementation and α-tocopherol supplementation on gene expression in healthy older adults. | Clinics (Sao Paulo) | 2019 | 30864639 | PubTator, text mining | PubMed |
| Allyl-Nickel Catalysis Enables Carbonyl Dehydrogenation and Oxidative Cycloalkenylation of Ketones. | J Am Chem Soc | 2019 | 30861346 | PubTator, text mining | PubMed |
| Interactions Between Enteroviruses and the Inflammasome: New Insights Into Viral Pathogenesis. | Front Microbiol | 2019 | 30858838 | PubTator, text mining | PubMed |
| A Randomized Controlled Trial of Chuanhutongfeng Mixture for the Treatment of Chronic Gouty Arthritis by Regulating miRNAs. | Evid Based Complement Alternat Med | 2019 | 30854012 | PubTator, text mining | PubMed |
| Innate Immune Signaling Organelles Display Natural and Programmable Signaling Flexibility. | Cell | 2019 | 30853218 | PubTator, text mining | PubMed |
| Oral Mucosal Epithelial Cells. | Front Immunol | 2019 | 30837987 | PubTator, text mining | PubMed |
| First Case of Patient With Two Homozygous Mutations in MYD88 and CARD9 Genes Presenting With Pyogenic Bacterial Infections, Elevated IgE, and Persistent EBV Viremia. | Front Immunol | 2019 | 30837984 | PubTator, text mining | PubMed |
| Design, Synthesis and Biological Evaluation of Isoxazole-Based CK1 Inhibitors Modified with Chiral Pyrrolidine Scaffolds. | Molecules | 2019 | 30832206 | PubTator, text mining | PubMed |
| Discovery of potent IRAK-4 inhibitors as potential anti-inflammatory and anticancer agents using structure-based exploration of IRAK-4 pharmacophoric space coupled with QSAR analyses. | Comput Biol Chem | 2019 | 30818109 | PubTator, text mining | PubMed |
| TNFAIP3, TNIP1, and MyD88 Polymorphisms Predict Septic-Shock-Related Death in Patients Who Underwent Major Surgery. | J Clin Med | 2019 | 30813592 | PubTator, text mining | PubMed |
| Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21. | Front Immunol | 2019 | 30800129 | PubTator, text mining | PubMed |
| Single Cell Profiling Reveals PTEN Overexpression in Influenza-Specific B cells in Aging HIV-infected individuals on Anti-retroviral Therapy. | Sci Rep | 2019 | 30792481 | PubTator, text mining | PubMed |
| Complexities of Type I Interferon Biology: Lessons from LCMV. | Viruses | 2019 | 30791575 | PubTator, text mining | PubMed |
| Role of self-organising myddosome oligomers in inflammatory signalling by Toll-like receptors. | BMC Biol | 2019 | 30786893 | PubTator, text mining | PubMed |
| The Evolving Role of TRAFs in Mediating Inflammatory Responses. | Front Immunol | 2019 | 30778351 | PubTator, text mining | PubMed |
| Clinical, Immunological, and Molecular Findings in 57 Patients With Severe Combined Immunodeficiency (SCID) From India. | Front Immunol | 2019 | 30778343 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=93